| |
|
|
|
Aquestive Therapeutics Inc  
|
|
4.1621 0.012 (0%) |
09-17 09:46 |
|
Open: |
4.18 |
Pre close: |
4.15 |
Target:
|
5.06
|
|
High: |
4.21 |
Low: |
4.1621 |
Resistance:
|
4.33
4.80
|
|
Volume: |
21,595 |
Market Cap: |
162M |
Support:
|
3.57
2.97
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.26
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
4.22  |
Signal(12,26,9): |
0.17 |
|
MA(100): |
3.83 |
Stochastic Oscillator |
%K(14,3):
|
33.51 |
|
MA(250): |
4.89 |
%D(3): |
44.69 |
|
Average Volume(K) |
3-Month: |
2324968
|
52-Week |
High:
|
9.09 |
|
10-Days: |
1073782 |
Low: |
3.10 |
|
RSI |
RSI(14):
|
50.20 |
Change(%): |
-54.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.579 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
36.59 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-37.1 |
Shares Float (M) |
34.32 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.98 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
26.9 |
% Held by Institutions |
45.77 |
|
Forward EPS |
-2.610 |
Gross Profit (p.s.) |
0.899 |
Shares Short (K) |
2980 |
|
Book Value (p.s.) |
-1.430 |
EBITDA (p.s.) |
-0.931 |
P/E |
-2.63 |
|
Sales Per Share |
1.318 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.90 |
|
Profit Margin |
-111.86 |
Operating Cash Flow
(M) |
-45.92 |
P/S |
3.15 |
|
Operating Margin |
-77.91 |
Levered Free Cash Flow
(M) |
-22.02 |
P/CF |
-3.31 |
|
|
|
|
|
|
